Key features and details
- Rabbit polyclonal to CDA
- Suitable for: WB, ELISA, IHC-P
- Reacts with: Human
- Isotype: IgG
Product nameAnti-CDA antibody
See all CDA primary antibodies
DescriptionRabbit polyclonal to CDA
Tested applicationsSuitable for: WB, ELISA, IHC-Pmore details
Species reactivityReacts with: Human
Synthetic peptide corresponding to N-terminal residues of human CDA
- Paraffin embedded human spleen tissue
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid repeated freeze / thaw cycles.
Storage bufferPreservative: 0.01% Sodium azide
Constituents: 50% Glycerol, PBS
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab78231 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||Use a concentration of 1 µg/ml. Predicted molecular weight: 16 kDa.|
|ELISA||Use a concentration of 1 µg/ml.|
|IHC-P||Use a concentration of 5 µg/ml.|
RelevanceCDA (Cytidine deaminase) scavengers exogenous and endogenous cytidine and 2'-deoxycytidine for UMP synthesis. Growth inhibition of granulocyte-macrophage colony foring cells by human cytidine deaminase requires the catalytic function of the protein. It is highly expressed in granulocytes.
- CDD antibody
- Cytidine aminohydrolase antibody
- Cytidine deaminase antibody
- EC 126.96.36.199 antibody
Immunohistochemical analysis of CDA expression in Formalin-Fixed Paraffin Embedded human spleen using 5 µg/ml ab78231
Anti-CDA antibody (ab78231) at 1 µg/ml + Human spleen tissue lysate - total protein (ab29699) at 10 µg
Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (ab97080) at 1/5000 dilution
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 16 kDa
Observed band size: 17 kDa why is the actual band size different from the predicted?
Exposure time: 4 minutes
ab78231 has been referenced in 1 publication.
- Murakami Y et al. The augmented expression of the cytidine deaminase gene by 5-azacytidine predicts therapeutic efficacy in myelodysplastic syndromes. Oncotarget 10:2270-2281 (2019). PubMed: 31040918